Clinical trials sites in the United States for Ixiaro in children under 17. Centers for Disease Control and Prevention website. Available at
http://www.cdc.gov/ncidod/dvbid/jencephalitis/resources/UpdtJEVaccChildren%5FWeb%5FTable1.pdf. Accessed November 19, 2013.
Dubischar-Kastner K, Kaltenboeck A, et al. Safety
analysis of a Vero cell culture-derived Japanese encephalitis vaccine, IXIARO
(IC51), in 6 months of follow-up.
Fischer M, Lindsey N, et al; Centers for Disease Control and
Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory
Committee on Immunization Practices (ACIP).
MMWR Recomm Rep.
Halstead SB, Thomas SJ. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
Expert Rev Vaccines. 2011;10(3):355-364.
Halstead SB, Thomas SJ. Japanese encephalitis: new options for active
Clin Infect Dis.
Japanese encephalitis. EBSCO DynaMed website. Available at:
https://dynamed.ebscohost.com/about/about-us. Updated May 22, 2013. Accessed November 19, 2013.
Japanese encephalitis vaccine: What you need to know. Centers for Disease Control and Prevention website. Available at: http://www.immunize.org/vis/je%5Fixiaro.pdf. Updated December 7, 2011. Accessed November 19, 2013.
Lehtinen VA, Huhtamo E, Siikamäki H, Vapalahti O. Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand.
J Clin Virol. 2008;43(1):93-95.
Wilder-Smith A, Halstead SB. Japanese encephalitis: update on vaccines and
Curr Opin Infect Dis.